Inventor · disambiguated record
Christian Montalbetti
Also filed as: MONTALBETTI CHRISTIAN · MONTALBETTI CHRISTIAN A G N
4 granted patents·8 pending applications·4 citations·filing 2005–2023
61Inventor score
Files withGENENTECH INC3INVENTIVA3IRBM S P A2C N C C S S C A R L COLLEZIONE NAZ DEI COMPOSTI CHIMICI E CENTRO SCREENING1DISC MEDICINE INC1
Top patents by PatentIndex Score
12 records- 0172US9034866B2Tricyclic compounds and methods of use thereforGENENTECH INC·Filed 2013·Granted May 19, 2015·2 cites·29 claims
- 0271US10414739B2Compounds as inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesotheliomaINVENTIVA·Filed 2016·Granted Sep 17, 2019·2 cites·18 claims
- 0358US2025353853A1Flavivirus inhibitorsIRBM S P A·Filed 2023·Application pending·0 cites
- 0452US2024317801A1Peptidomimetic matriptase 2 inhibitors and uses thereofDISC MEDICINE INC·Filed 2021·Application pending·0 cites
- 0552US2015038460A16,5-Heterocyclic Propargylic Alcohol Compounds and Uses ThereforGENENTECH INC·Filed 2014·Application pending·0 cites
- 0646US11999758B2Inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of cancerINVENTIVA·Filed 2019·Granted Jun 4, 2024·0 cites·19 claims
- 0746US2024109900A1Azabicyclic shp2 inhibitorsIRBM S P A·Filed 2022·Application pending·0 cites
- 0843US2024239799A1(s)-1-(5-((pyridin-3-yl)thio)pyrazin-2-yl)-4'h,6'h-spiro[piperidine-4,5'-pyrrolo [1,2-b]pyrazol]-4'-amine derivatives and similar compounds as shp2 inhibitors for the treatment of e.g. cancerC N C C S S C A R L COLLEZIONE NAZ DEI COMPOSTI CHIMICI E CENTRO SCREENING·Filed 2022·Application pending·0 cites
- 0940US8901313B26,5-heterocyclic propargylic alcohol compounds and uses thereforSTABEN STEVEN·Filed 2012·Granted Dec 2, 2014·0 cites·21 claims
- 1039US2015166569A1Tricyclic compounds and methods of use thereforGENENTECH INC·Filed 2015·Application pending·0 cites
- 1137US2007299102A1Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of CancerTOPOTARGET AS·Filed 2005·Application pending·0 cites
- 1234US2020115353A1New compounds inhibitors of the yap/taz-tead interaction and their use in the treatment of malignant mesotheliomaINVENTIVA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian Montalbetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →